Global Key SolutionsGKS
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Square Vape Labs Inc.
WARNING LETTER
•Square Vape Labs Inc.•February 26, 2021

FDA WARNING_LETTER - Square Vape Labs Inc. - February 26, 2021

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents
Record Details

The FDA Center for Tobacco Products issued a Warning Letter to Anthony Napolitano regarding e-liquid products manufactured and sold by Square Vape Labs via squarevapelabs.com. The FDA determined that e-liquid products, including "Pound," "Teddy Roos," and "Fruit Stripe Gum," are tobacco products under section 201(rr) of the FD&C Act and are subject to FDA regulation.

The primary violation is the marketing of "new tobacco products" without required premarket authorization orders, as mandated by section 910(a) of the FD&C Act. These products were not commercially marketed in the U.S. as of February 15, 2007, and lack FDA marketing authorization, rendering them adulterated under section 902(6)(A) and misbranded under section 903(a)(6) of the FD&C Act.

The letter emphasizes the firm's responsibility, as a registered manufacturer with over 38,800 listed products, to ensure compliance with the FD&C Act and FDA regulations (21 C.F.R. Parts 1140, 1141, and 1143). Failure to comply may result in civil money penalties, seizure, and/or injunction. The firm must submit a written response within 15 working days detailing corrective actions, including discontinuation of violative sales and a plan for

Company
Square Vape Labs Inc.
Inspection Date
February 26, 2021
Product Type
Tobacco
Office
Center for Tobacco Products
Person
  • Ann Simoneau (Director)
Open in Dashboard

ID · 6e6672c4-cbfc-4755-9ec3-69e71e5b354b

Violation Codes10
21 U.S.C. 321(rr)21 U.S.C. 387a(b)21 U.S.C. 387j(a)21 U.S.C. 387j(c)(1)(A)(i)21 U.S.C. 387e(j)21 U.S.C. 387e(j)(1)(A)(ii)21 U.S.C. 387e(j)(3)21 U.S.C. 30121 CFR 1100.121 CFR 1140

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
[email protected]
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.